Sanai Health GP (01889) suggested conducting stock capital reorganization.
Sanai Health GP (01889) has announced that the company proposes the following share capital restructuring, involving share consolidation, change of nominal value per share, and...
Express News | Sanai Health Industry - Consolidation on Basis Every 25 Shares of HK$0.01 Each Be Consolidated Into 1 Share of HK$0.25 Each
Express News | Sanai Health Industry Group Co Ltd - Proposed Share Consolidation
Sanai Health GP (01889) appointed Xie Haijing as an executive director.
Sanai Health GP (01889) announced that Xie Haijing has been appointed as an executive director, effective from June 28th, 2024...
Express News | Sanai Health Industry - Gao Borui Resigned as Executive Director
Express News | Sanai Health Industry - Xie Haijing Appointed Executive Director
SANAI HEALTH GP: Annual Report 2023
A total of 612 million new shares were issued by Sanai Health Group (01889) in exchange for convertible stock notes
According to the Zhitong Finance App, Sanai Health Group (01889) issued an announcement to issue and distribute 349 million new shares on April 23, 2024 in exchange for convertible notes due in 2026 with a principal amount of HK$34.2 million based on an adjusted exchange price of HK$0.098 per share. On April 23, 2024, 263 million new shares were issued and distributed in exchange for convertible notes due 2026 with a principal amount of HK$25.8 million, based on an adjusted conversion price of HK$0.098 per share.
Sanai Health Unit to Offload 59% Stake in Genetic Testing Provider
Sanai Health Group (01889) plans to sell 59% of Zentrogene Bioscience Laboratory Limited's shares for HK$22 million
Sanai Health Group (01889) announced that on April 17, 2024, the company is a wholly-owned subsidiary of Sanai International Investment...
Investors Give Sanai Health Industry Group Company Limited (HKG:1889) Shares A 26% Hiding
Sanai Health Group (01889) announced annual results. Profit attributable to shareholders was 18.633 million yuan, a year-on-year decrease of 36.23%
According to the Zhitong Finance App, Sanai Health Group (01889) announced its 2023 annual results, with revenue of about 122 million yuan (RMB, same below); a year-on-year decrease of about 30.59%; profit attributable to company owners was 18.633 million yuan, a year-on-year decrease of 36.23%; profit per share was 0.58 points. According to reports, the decline in earnings was mainly due to a decrease in sales of self-produced pharmaceutical products and sales of pharmaceutical products from other non-competitive pharmaceutical companies.
SANAI HEALTH GP: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Sanai Health Group (01889) Fa Ying Guang expects net profit attributable to owners to be reduced significantly by no more than 40% in 2023
Sanai Health Group (01889) announced that compared with the same period in 2022, the group is expected to achieve...
SANAI HEALTH GP: PROFIT WARNING
Sanai Health Group (01889.HK) plans to hold a board meeting on March 27 to consider and approve the annual results
Gelonghui, March 15, 丨 Sanai Health Group (01889.HK) announced that the company will hold a board meeting on March 27, 2024 (Wednesday) to consider and approve the audited financial results of the company and its subsidiaries for the financial year ended 31 December 2023.
Sanai Health Group (01889) plans to acquire 51% of Beijing Hangyang Health Technology's shares for 33.15 million yuan
Sanai Health Group (01889) announced that on March 1, 2024, the company's wholly-owned subsidiary Keibafro Technology Co., Ltd...
Sanai Health Group [01889] now reports HK$0.043, a decrease of 12.25%
As of 15:03, Sanai Health Group [01889] reported HK$0.043, down HK$0.006 or 12.25% from yesterday's closing price, with a turnover of HK$17,200. Today's high price was HK$0.044 and the lowest price was HK$0.043. Based on yesterday's closing price, the 10-day average price was HK$0.05, and the 50-day average price was HK$0.06. The current price-earnings ratio was 4.58 times, and the 14-day strength and weakness index was reported at 31.03.
Sanai Health Group [01889] now reports HK$0.043, a decrease of 10.42%
As of 13:27, Sanai Health Group [01889] reported HK$0.043, down HK$0.005 or 10.42% from yesterday's closing price, with a turnover of HK$22,700. Today's high price was HK$0.052, and the lowest price was HK$0.043. Based on yesterday's closing price, the 10-day average price was HK$0.05, and the 50-day average price was HK$0.06. The current price-earnings ratio was 4.49 times, and the 14-day strength and weakness index was reported at 33.33.
Benign Growth For Sanai Health Industry Group Company Limited (HKG:1889) Underpins Stock's 28% Plummet
No Data